For research, professional, and investigational evaluation only. No exosome product is FDA-approved for therapeutic use in humans.

Research compound guide

Buy Semaglutide Research Compound.

Semaglutide is a GLP-1 receptor agonist that has become one of the most researched peptides in metabolic and endocrine research. This guide covers sourcing semaglutide for research — specifications, quality evaluation, COA requirements, and storage protocols.

What is semaglutide?

Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes management. It is a modified GLP-1 analog with a C17 fatty acid side chain that enables albumin binding and extended half-life. Research into semaglutide has expanded significantly to include studies on appetite regulation, weight management, cardiovascular outcomes, and neuroprotective effects.

Semaglutide supplied by B&H Bio is a research compound for laboratory and preclinical evaluation. It is not for human consumption.

Semaglutide specifications

SpecificationStandardWhy it matters
Molecular formulaC₁₈₇H₂₉₁N₄₅O₅₉Confirms molecular identity
Molecular weight~4,113.58 g/molUsed for molar concentration calculations
Purity≥ 99% (HPLC)Ensures research reproducibility
FormLyophilized powderStable for shipping and storage
SequenceGLP-1(7-37) analog with Aib⁸ and C17 fatty acid side chainConfirms structural modification
AppearanceWhite to off-white powderVisual quality indicator

How to evaluate semaglutide quality

  • HPLC purity verificationThe COA must show HPLC chromatographic data with a quantified purity percentage. "Passes" without a number is insufficient.
  • Mass spectrometry confirmationMS data confirms the molecular weight matches the expected 4,113.58 g/mol, verifying the correct compound was synthesized.
  • Amino acid analysisConfirms the peptide sequence and modifications are correct, including the Aib substitution and fatty acid conjugation.
  • Endotoxin testingFor in vitro and in vivo research, endotoxin levels must be reported on the COA.

COA requirements for semaglutide

A research-grade semaglutide COA should document:

  • Identity testingHPLC retention time comparison and/or mass spectrometry molecular weight confirmation.
  • Purity quantificationNumerical HPLC purity (≥99%), not a pass/fail statement.
  • Endotoxin levelMeasured by LAL assay with the specific value reported.
  • Lot number and manufacture dateFor traceability and shelf-life calculation.
  • Third-party verificationIndependent lab (e.g., Eurofins) testing provides the highest confidence level.

Semaglutide storage and handling

Lyophilized

-20°C storage

Store lyophilized semaglutide at -20°C protected from light. Stable for 24+ months under proper conditions.

Reconstituted

2-8°C storage

After reconstitution with bacteriostatic water, store at 2-8°C. Use within the supplier-recommended window. Avoid freeze-thaw.

Light sensitivity

Protect from light

Semaglutide is light-sensitive. Store in amber vials or wrapped in foil. Minimize exposure during handling.

Semaglutide research applications

  • Metabolic researchGLP-1 receptor signaling studies, insulin secretion assays, and glucose homeostasis models.
  • Appetite and weight regulationHypothalamic signaling studies and feeding behavior research in animal models.
  • Cardiovascular researchCardioprotective effects and vascular function studies.
  • Neuroprotective researchEmerging studies on GLP-1 receptor activation in neurodegeneration models.
  • Pharmacokinetic studiesHalf-life, bioavailability, and tissue distribution research.

Why choose B&H Bio for semaglutide

  • Batch-linked documentationEvery semaglutide lot has linked quality records available for professional review.
  • Lot traceabilityUnique lot numbers reconcilable with COA documentation.
  • Research-use-only complianceClear RUO labeling — no therapeutic claims, no ambiguity.

Ready to evaluate?

Request semaglutide documentation.

Match your research requirements to current-batch quality records.

Request documentation →